CCEP's August Earnings: The Gap Between Buyback Confidence and Single-Digit Growth Widens
Coca-Cola Europacific Partners Plc (CCEP) is scheduled to report earnings on June 30, 2026, with the stock trading at $101.38 heading into the release. With the company delivering strong Q1 2026 results—including 9.4% revenue growth and solid volume gains—investors will be watching closely to see if CCEP can maintain momentum amid commodity cost pressures and evolving consumer preferences. The central question: can management sustain its mid-term growth targets while navigating a challenging macroeconomic backdrop?
Part 1: Earnings Preview
Coca-Cola Europacific Partners is the world's largest independent Coca-Cola bottler by revenue, serving approximately 600 million consumers across 31 countries in Europe and the Asia-Pacific region. The company manufactures, distributes, and sells a broad portfolio of non-alcoholic ready-to-drink beverages including sparkling soft drinks, water, sports drinks, and energy drinks.
CCEP will report earnings on June 30, 2026, though specific consensus EPS and revenue estimates for the upcoming quarter are not available. The company most recently reported Q4 2025 results with EPS of $2.27, reflecting continued profitability as the business scales. Looking at year-over-year comparisons, the company has demonstrated consistent earnings growth, with management guiding to full-year 2026 operating profit growth of approximately 7% and free cash flow generation of at least €1.7 billion.
Three key themes define this earnings story:
Portfolio Premiumization and Zero-Sugar Growth: CCEP continues to shift its mix toward higher-margin products, particularly zero-sugar variants and energy drinks. Management has emphasized consumer-centric innovation as a core growth driver, with the zero-sugar and energy drink portfolio expansion representing a critical pathway to margin improvement. This strategic pivot addresses changing consumer preferences while supporting revenue per case growth.
Commodity Cost Management and Pricing Power: With approximately 85% of commodities hedged for 2026 and cost of sales expected to rise about 1.5% per case, CCEP's ability to maintain pricing discipline while protecting volume will be crucial. The company's Q1 2026 performance showed an 8.5% volume increase (including additional consumption days), demonstrating that strategic pricing hasn't significantly eroded demand. Investors will scrutinize whether this balance can be sustained.
Capital Allocation and Shareholder Returns: CCEP has committed to a €1 billion share buyback for 2026 while maintaining a dividend payout ratio of approximately 50% that grows with earnings. The company aims to operate toward the bottom of its 2.5x–3x net debt/EBITDA range (currently just below 2.7x), balancing growth investment with shareholder returns. With CapEx guidance unchanged at approximately €1 billion and strong free cash flow generation, the sustainability of this capital allocation framework will be a focus.
Analysts remain constructive heading into the release. The consensus view reflects confidence in CCEP's execution capabilities and market positioning, with management's reaffirmation of mid-term targets (4% revenue growth and 7% operating profit growth) providing a clear roadmap. Commentary from recent quarters highlights the company's success in gaining market share through "great execution" and its role as "the leading value creator for our customers." However, analysts also acknowledge that "material challenges remain," particularly around sustaining volume growth in a price-sensitive environment and managing the ongoing shift in consumer preferences toward healthier beverage options.
Part 2.2: Options Market Expected Move
| Metric | Value |
|---|---|
| Expiration Date | 07/17/26 (DTE 18) |
| Expected Move | $3.37 (3.33%) |
| Expected Range | $98.01 to $104.75 |
| Implied Volatility | 19.48% |
The options market is pricing an expected move of ±3.33% ($3.37) through the July 17, 2026 expiration, with the stock anticipated to trade between $98.01 and $104.75. Without historical earnings move data available for comparison, this expected move provides the primary quantitative framework for gauging potential post-earnings volatility, suggesting moderate price action relative to the stock's current level.
Part 3: What Analysts Are Saying
Analyst sentiment on CCEP is decidedly bullish heading into earnings. The consensus rating stands at 4.20 out of 5.0, reflecting a Strong Buy recommendation, with the average price target of $107.67 implying 6.2% upside from the current price of $101.38. The target range spans from a low of $81.00 to a high of $118.00, indicating some divergence in views but with the mean target comfortably above current levels.
The ratings breakdown shows strong conviction: 10 analysts rate the stock a Strong Buy, zero have Moderate Buy ratings, 4 maintain Hold ratings, and just 1 analyst has a Strong Sell rating. This 10-4-1 split across 15 total recommendations demonstrates that two-thirds of the analyst community sees compelling value at current levels.
Sentiment has improved over the past month, with Strong Buy ratings increasing from 9 to 10. The average recommendation has strengthened from 4.14 to 4.20, reflecting growing confidence in CCEP's execution and growth trajectory. This positive shift aligns with the company's strong Q1 2026 performance and management's reaffirmation of full-year guidance, suggesting analysts view the current setup as favorable for continued outperformance.
Part 4: Technical Picture
CCEP enters earnings with strong technical momentum. The Barchart Technical Opinion currently shows a 72% Buy signal, unchanged from last week but representing a significant improvement from the 40% Sell signal just one month ago. This dramatic reversal reflects the stock's recent strength, with shares climbing above all key moving averages.
Timeframe Analysis:
- Short-term (50% Buy): Moderate buy signal indicates positive near-term momentum, though not at extreme levels
- Medium-term (50% Buy): Consistent moderate buy reading suggests steady intermediate-term trend support
- Long-term (100% Buy): Strong buy signal reflects robust longer-term uptrend and structural strength
Trend Characteristics: The technical setup shows Average strength with the Strongest direction, indicating a well-established uptrend with clear momentum heading into the earnings release.
The stock is trading at $101.38, positioned above all major moving averages: the 5-day ($99.83), 10-day ($98.88), 20-day ($96.77), 50-day ($95.17), 100-day ($97.03), and 200-day ($93.52). This complete alignment above all moving averages is a classically bullish configuration, suggesting strong underlying support and positive trend structure. The progressive stacking of moving averages—with shorter-term averages above longer-term ones—confirms the uptrend remains intact.
| Period | Value | Period | Value |
|---|---|---|---|
| 5-Day MA | $99.83 | 50-Day MA | $95.17 |
| 10-Day MA | $98.88 | 100-Day MA | $97.03 |
| 20-Day MA | $96.77 | 200-Day MA | $93.52 |
The technical picture heading into earnings is supportive, with CCEP trading near recent highs and maintaining position above all key moving averages. The 200-day moving average at $93.52 provides a significant support level approximately 8% below current prices, while the stock's position above shorter-term averages suggests near-term momentum remains positive. With the options market pricing a ±3.33% move and the stock in a confirmed uptrend, the setup favors bulls, though the proximity to potential resistance near the $104.75 upper expected move boundary could cap immediate upside if results merely meet expectations.